roflumilast 3 MG/ML Topical Foam [Zoryve]

RxNorm concept 2671684, branded drug (sbd). Prescribable name: ZORYVE 0.3 % Topical Foam.

RxCUI: 2671684
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2671684 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

roflumilast 1091836

Other names

Zoryve 0.3 % Topical Foam; Zoryve 3 MG/ML Topical Foam

Related concepts

roflumilast 3 MG/ML (SCDC, consists of)
roflumilast 3 MG/ML [Zoryve] (SBDC, consists of)
Topical Foam (DF, has dose form)
Zoryve (BN, has ingredient)
roflumilast 3 MG/ML Topical Foam (SCD, tradename of)

Linked data

NDCs

80610043060

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2671684 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2671684 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2671684. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.